Paper · 2175672
Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes.
Kirkwood JM and 1 other. Cancer Immunol Immunother, 1990. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes. Papers, record 2175672. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2175672
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neoplasm | Major topic |
| B-Lymphocytes | Major topic |
| Immunoglobulin G | Major topic |
| Immunoglobulin M | Major topic |
| Melanoma | Major topic |
| Antibody Specificity | |
| Cell Transformation, Viral | |
| Herpesvirus 4, Human | |
| Humans | |
| Lymph Nodes |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,291,057 | Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6291057 | PubMed |
| 2 | 3,108,402 | Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. | J Immunol | 1987 | https://conductscience.org/library/papers/3108402 | PubMed |
| 3 | 6,094,060 | Production of autoantibodies to cellular antigens by human B cells transformed by Epstein-Barr virus. | Clin Immunol Immunopathol | 1984 | https://conductscience.org/library/papers/6094060 | PubMed |
| 4 | 233,917 | Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. | J Exp Med | 1977 | https://conductscience.org/library/papers/233917 | PubMed |
| 5 | 6,292,911 | Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6292911 | PubMed |
| 6 | 6,744,327 | Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum. | Cancer Res | 1984 | https://conductscience.org/library/papers/6744327 | PubMed |
| 7 | 3,031,684 | Cell-surface antigens of melanoma recognized by human monoclonal antibodies. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3031684 | PubMed |
| 8 | 6,933,476 | Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6933476 | PubMed |
| 9 | 6,189,902 | Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. | J Immunol | 1983 | https://conductscience.org/library/papers/6189902 | PubMed |
| 10 | 6,403,623 | An enzyme immunofiltration assay useful for detecting human monoclonal antibody. | J Immunol Methods | 1983 | https://conductscience.org/library/papers/6403623 | PubMed |
1 to 10 of 32
See all 32 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23,454,746 | IgG4 subclass antibodies impair antitumor immunity in melanoma. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23454746 | PubMed |
| 21,559,411 | Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodies. | PLoS One | 2011 | https://conductscience.org/library/papers/21559411 | PubMed |
| 20,518,060 | Viral transformation for production of personalized type I interferons. | Biotechnol J | 2010 | https://conductscience.org/library/papers/20518060 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2175672
GET https://conductscience.org/api/papers/v1/2175672/references?page=2